Deborah Birx Innoviva, Inc. (INVA) insider trading activity

INVA Quotes by TradingView

Deborah Birx is Director of Innoviva, Inc.. Currently has a direct ownership of 58,984 shares of INVA, which is worth approximately $1.16 Million. The most recent transaction as insider was on May 22, 2023, when has been sold 16,495 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 59K
0% 3M change
0% 12M change
Total Value Held $1.16 Million

Deborah Birx Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 22 2023
BUY
Grant, award, or other acquisition
-
16,495 Added 21.85%
58,984 Common Stock
Apr 25 2022
BUY
Grant, award, or other acquisition
-
12,647 Added 22.94%
42,489 Common Stock
May 14 2021
BUY
Grant, award, or other acquisition
-
17,482 Added 36.94%
29,842 Common Stock
Mar 29 2021
BUY
Grant, award, or other acquisition
-
1,612 Added 11.54%
12,360 Common Stock

Also insider at

ARMP
Armata Pharmaceuticals, Inc. Healthcare
Chief Executive Officer
DB

Deborah Birx

Director
Burlingame, CA

Track Institutional and Insider Activities on INVA

Follow Innoviva, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INVA shares.

Notify only if

Insider Trading

Get notified when an Innoviva, Inc. insider buys or sells INVA shares.

Notify only if

News

Receive news related to Innoviva, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INVA